The company is also in the process of shipping QIAstat-Dx testing kits to public health institutions in other regions, including Europe, South-East Asia and the Middle East. To read this article on Zacks.com click here. Enterprise Products Partners (EPD) We’ll start in the energy sector, a business segment long known for both high cash flows and high dividends. The … The test has been authorized by FDA under an EUA for use by authorized laboratories. Trelegy was initially approved in the US as the first once-daily single inhaler triple therapy for the treatment of COPD. The retirement crisis is both not as bad as it’s made out to seem—and also worse. About the BD Veritor™ System for Rapid Detection of SARS-CoV-2 Assay The BD Veritor™ Plus System for Rapid Detection of SARS-CoV-2 Assay has been CE marked to the IVD Directive (98/79/EC), but has not been cleared or approved by FDA. The stock has a Zacks Rank #2 (Buy). ** BD FocalPoint Slide Profiler Workstation is currently undergoing patch validation for CVE-201-20685 † BD Veritor™ Connect NUC, BD MAX and BD Kiestra™ are currently undergoing patch validation for CVE-201-20685 and CVE-2019-6109. By working in close collaboration with customers, BD can help enhance outcomes, lower costs, increase efficiencies, improve safety and expand access to health care. The CARES Act requires COVID-19 testing facilities to report testing data to local and federal health authorities daily, including the number of tests performed, results and key patient demographics. The stock’s $24.63 average price target suggests an upside of 9% from the current share price of $22.65. Whether markets move up or down, every investor loves a bargain. BD Statement on COVID-19 (Coronavirus) Updated November 2020. And while the COVID strain is matched by current vaccines, there is still a risk that a new strain will develop that is not covered by existing vaccinations – which could restart the cycle of lockdowns and economic decline. from 8 AM - 9 PM ET, HVAC (Heating, Ventilation and Air-Conditioning), Machine Tools, Metalworking and Metallurgy, Aboriginal, First Nations & Native American. To this end, Porges rates TBPH an Outperform (i.e. At 8.6% interest on its savings accounts, crypto fintech platform BlockFi is offering an interesting option for savers disappointed with low rates. That’s not all. The test is authorized in the United States for the duration of the declaration that circumstances exist justifying the authorization of emergency use of in vitro diagnostic tests for detection and/or diagnosis of COVID-19 under Section 564(b)(1) of the Act, 21 U.S.C. This kit allows BD MAX™ System users to run a single module that tests concurrently for COVID-19 and Influenza (Flu) and Respiratory Syncytial Virus (RSV). Hence, the latest development has been a well-timed one for BD. This is up from the previous payment of 44 cents, and marks the first increase in two years. The shares are selling for $21.68, and the average price target of $28.75 suggests an upside of ~32% on the one-year timeframe. by sending BD MAX™ systems to develop tests for coronavirus5 BD announces product donations valued at $300,000 to Wuhan Red Cross and $50,000 to Project Hope5 The WHO announces official name for the disease caused by the novel coronavirus: COVID-192 CerTest Biotec and BD announce COVID-19 diagnostic test for BD MAX™ System with CE mark6 Zacks Investment Research. Most financial markets will be closed for the celebration of the civil rights leader's life, the first one since protests over the killing of George Floyd touched off massive protests across the nation. That number was down year-over-year, slipping 5.4%, but came in more than 6% above the Q3 forecast. COVID-19 stay-at-home orders and the closing of movie theaters have hobbled Warner Bros.' film business. The assay is based on the same viral RNA targeting sequences and real-time PCR detection method as the test developed by the U.S. Centers for Disease Control and Prevention (CDC). The subscriber growth was driven by the new 5G network rollout – and by premium content services. This BD MAX protocol is fully automated and the turnaround time from sample to results is approximately 2.5 h for 24 samples compared to 4.8 h by in-house real-time RT-PCR. Learn more about BD Synapsys. About BD BD is one of the largest global medical technology companies in the world and is advancing the world of health by improving medical discovery, diagnostics and the delivery of care. BD has a presence in virtually every country and partners with organizations around the world to address some of the most challenging global health issues. EPD’s Strong Buy consensus rating is based on a unanimous 9 Buys. Chicago-based Boeing still reported more cancellations than new orders for its 737 Max jet, which was … BioGX developed the assay for the BD MAX™ System in their Sample-Ready™ ready-to-use format to detect the presence of the SARS-CoV-2 virus, the cause of COVID-19. Some of McCourt’s colleagues among the Raymond James analyst cadre are keeping these risks in mind, and putting their imprimatur on strong dividend stocks. President-elect Joe Biden’s $1.9 trillion “rescue plan” released on Thursday calls for three key tax improvements for 2021 that would help Americans across the income spectrum. active COVID-19 infection and can give the virus to others. The $1.9-trillion Joe Biden plan to speed recovery won't include tax hikes. Beyond TBPH’s commercial/partnered assets, the company is also developing an improved JAK inhibitor (JAKi) partnered with JNJ (OP) for inflammatory bowel disease (IBD), and a norepinephrine and serotonin reuptake inhibitor (NSRI) TD-9855 (ampreloxetine) for neurogenic orthostatic hypotension (nOH). Raymond James analyst Frank Louthan sees AT&T as a classic defensive value stock, and describes T’s current state as one with the bad news ‘baked in.’ “[We] believe there is more that can go right during the next 12 months than can get worse for AT&T. ZARAGOZA, Spain and FRANKLIN LAKES, N.J., March 10, 2020 /PRNewswire/ -- CerTest Biotec, along with BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that the VIASURE SARS-CoV-2 Real Time PCR Detection Kit adapted for the BD MAX ™ System has been CE marked to the IVD Directive (98/79/CE). Will the real retirement crisis please stand up? Its acquisition of TimeWarner (now WarnerMedia), in a process running between 2016 and 2018, has given the company a large stake in the mobile content streaming business. The company held up its reputation as a dividend champ, and has made its most recent dividend declaration for payment in February 2021. These patches will reduce risk of BD … The BD Synapsys™ solution's new capabilities allow global customers to create general-purpose reports with COVID-19 data from their BD Veritor™ and/or BD MAX™ systems. So, how are investors supposed to distinguish between the names poised to get back on their feet and those set to remain down in the dumps? Virgin Galactic and other space stocks jumped Thursday on hopes for a new space-focused exchange traded fund. Notably, the company recently introduced the COR molecular system, which is also expected to be sold in Europe. (To watch Louthan’s track record, click here) What does the rest of the Street think? Revenues in 3Q20 were $42.3 billion, 5% below the year-ago quarter. By 2020, it's predicted to blast through the roof to $77.6 billion. It is very important to do your own analysis before making any investment. VIASURE Real Time PCR Detection Kits. For more information on BD, please visit bd.com. Revenues turned around, growing 27% sequentially to reach $6.9 billion in Q3. This empowers customers to focus on what matters most: Caring for their patients.". More importantly, the coronavirus vaccination program is proceeding, and reports are showing that Pfizer’s vaccine, one of two approved in the US, is effective against the new strain of the virus. "The solution's new encrypted reporting capabilities reduce the burden associated with manual reporting. See Zacks' 3 Best Stocks to Play This Trend >>, Click to get this free report Becton, Dickinson and Company (BDX) : Free Stock Analysis Report Stryker Corporation (SYK) : Free Stock Analysis Report QIAGEN N.V. (QGEN) : Free Stock Analysis Report Laboratory Corporation of America Holdings (LH) : Free Stock Analysis Report To read this article on Zacks.com click here. Here are trading hours, Bank of America's 8 Best Stocks to Buy in Q1, Dow Slides As Biden Stimulus Plan Raises These Fears; GM Reverses As IPO Stock Passes Buy, 2 “Strong Buy” Stocks Trading at Steep Discounts, Value stocks are about to come out of their coma, says index fund powerhouse Vanguard, Rally Quickly Turns 7 Penny Stocks Into Billion-Dollar Companies, Biden Pitches Stimulus Checks Now, Tax Hikes Soon To Beat Virus, Inequality; Dow Jones Falls, Virgin Galactic, Space Stocks Soar As Tesla Bull Eyes New ETF, The good news and ominous warnings in JPMorgan’s earnings call. It has not been authorized for use to detect any other viruses or pathogens. For comparison, the average dividend among tech sector peer companies is only 0.9%. You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here. The BD MAX system is cleared or approved by the U.S. FDA only when used with BD MAX ™ IVD assays, which have been cleared or approved by the FDA. FRANKLIN LAKES, N.J., Nov. 23, 2020 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced new reporting capabilities for COVID-19 data, enabling scheduled reports to be generated from BD Synapsys™ Informatics (version 3.84). Some left-for-dead penny stocks are now billion-dollar companies, thanks to the rally in the S&P 500 and other indexes. Marijuana stocks surged as a Democratic Senate adds to cannabis legalization momentum. TBPH shares are priced at $16.95, and their $33.60 average price target suggests a 97% upside from that level. YUPELRI underlies the lion’s share of Theravance’s revenue, which in Q3 reach $18.3 million. EPD has recently declared its 4Q20 dividend distribution, at 45 cents per common share. Over the past year, shares of BD have slipped 5.3% compared with the industry’s 13.5% decline. Tech stocks could come under pressure as President-elect Joe Biden's stimulus plan works its way through the U.S. economy. Notably, QIAGEN QGEN recently announced that it has shipped its newly-developed QIAstat-Dx Respiratory Panel 2019-nCoV test kit to four hospitals in China for evaluation. Additional configured reports can be developed, as needed. Like many biopharmas, Theravance has high overhead and its approved drugs are at the start of their profitable lives. On positive notes, free cash flow rose yoy from $11.4 billion to $12.1 billion, and the company reported a net gain of 5.5 million new subscribers. The company supports the heroes on the frontlines of health care by developing innovative technology, services and solutions that help advance both clinical therapy for patients and clinical process for health care providers. Q.: To lessen the death tax on my estate, if I put my Roth IRA in an irrevocable trust now and after my spouse and I die four years later, do my children afterward have six years or 10 years to invest all the money before they must dispose of the Roth money from the trust under the new rules of the 2019 SECURE Act? SARS-CoV-2 (the novel coronavirus that causes coronavirus disease 2019, or COVID-19) People around the world commonly get infected with human coronaviruses 229E, NL63, OC43, and HKU1. What is at least slightly different about Vanguard’s perspective is that its model suggests that investors have been correct in shunning value stocks, at least until the last few years. The VIASURE kit is available for use on the BD MAX System. The company was hurt by low prices and low demand in 1H20, but partially recovered in the second half. Feb. 12 marks the first date the Internal Revenue Service will start accepting and processing returns. The BD Veritor™ Plus System for Rapid Detection of SARS-CoV-2 Assay is not authorized for use by consumers or for at-home use. (See EPD stock analysis on TipRanks) AT&T, Inc. (T) AT&T is one of the market’s instantly recognizable stock. The BD MAX™ System is a fully-integrated, automated platform that performs nucleic acid extraction and real-time PCR providing results for up to 24 samples across multiple syndromes in less than three hours*. The Dow Jones slid lower amid fears Joe Biden's massive stimulus plan could lead to higher interest rates or tax hikes. Becton, Dickinson and Company (BDX) : Free Stock Analysis Report, Stryker Corporation (SYK) : Free Stock Analysis Report, QIAGEN N.V. (QGEN) : Free Stock Analysis Report, Laboratory Corporation of America Holdings (LH) : Free Stock Analysis Report. Meanwhile, LabCorp LH announced the availability of LabCorp 2019 Novel Coronavirus test, effective Mar 5. (PRNewsfoto/BD (Becton, … The ssRNA + genome is coiled inside a helical nucleocapsid of 9–11 nm diameter. Here are analysts' top stocks to buy in the first quarter.The S&P 500 closed out 2020 at all-time highs on optimism surrounding additional government stimulus measures and a potential global economic rebound in 2021. What are the fastest-growing stocks to watch in 2021? As with all CerTest tests, the VIASURE SARS-CoV-2 Real Time PCR Detection Kit for the BD MAX System is offered in a lyophilized format. The research programs range from Phase 1 to Phase 3 trials. Becton, Dickinson and Company BDX, also known as BD, along with CerTest Biotec, recently announced the receipt of CE mark for the VIASURE SARS-CoV-2 real time test adapted for the BD MAX System. Theravance Biopharma (TBPH) We will start with Theravance, a biopharmaceutical company that focuses on developing organ-specific medications. Despite the hefty losses incurred over the past 52 weeks, the two tickers have scored enough praise from the Street to earn a “Strong Buy” consensus rating. Looking at the consensus breakdown, opinions from other analysts are more spread out. The assay is based on the same viral RNA targeting sequences and real-time PCR detection method as the test developed by the U.S. Centers for Disease Control and Prevention ( CDC ). The company has a FY20 capital spending plan exceeding $1.7 billion, and is guiding toward $1.3 billion for FY21. Overall, however, revenues have conformed to the company’s historic pattern: The second and third quarters are relatively low, while the top line increases with cold weather in Q4 and peaks in Q1. Becton Dickinson rival Roche, which already received an emergency approval for the first U.S. approved test for Coronavirus strain COVID-19, said it began shipping an initial 400,000 test kids Friday. https://finance.yahoo.com/news/bd-max-gets-ce-mark-132201291.html The United States is currently devastated by the coronavirus outbreak as the number of confirmed cases has already surpassed 1,000, with 31 reported deaths. (See AT&T stock analysis on TipRanks) To find good ideas for dividend stocks trading at attractive valuations, visit TipRanks’ Best Stocks to Buy, a newly launched tool that unites all of TipRanks’ equity insights. BD and its 65,000 employees have a passion and commitment to help enhance the safety and efficiency of clinicians' care delivery process, enable laboratory scientists to accurately detect disease and advance researchers' capabilities to develop the next generation of diagnostics and therapeutics. Till date no vaccine has been invented to prevent coronavirus infection 2019 (COVID-19). Blijf altijd op de hoogte van het laatste nieuws via de snelste en leukste nieuwssite van Nederland, 24 uur per dag en 7 dagen in de week Both BD Veritor™ and BD MAX™ systems have been granted Emergency Use Authorization (EUA) by the U.S. Food and Drug Administration (FDA) to perform SARS-CoV-2 diagnostic testing. What’s New BD SARS-CoV-2 Reagents for BD MAX™ System. Tax season started Jan. 27 last year. It is very important to do your own analysis before making any investment. 25/09/2020 He doesn’t discount that, but sees it as unlikely to happen soon. Thus, the polymerase chain reaction (PCR) test, used for detecting COVID-19, is now available to clinical laboratories. Hence, the latest development is expected to ramp up BD MAX sales in Europe, thereby instilling investors’ optimism in the company. Max Lab, Saket, Delhi is now approved for Diagnostic Testing for the Novel Coronavirus (COVID-19) ICMR Registration Number: "MAXDL001" The tests and sample collection can happen only if prescribed by a qualified physician for COVID-19 test,which is a swab based test. Throw in the fact that shares are heavily shorted, and we believe this is a recipe for upside. § 360bbb-3(b)(1), unless the authorization is terminated or revoked sooner. "For COVID-19 testing facilities – including labs, hospitals and nursing homes – the BD Synapsys™ Informatics solution's new reporting capabilities, supported by secure connectivity, simplifies the process of reporting test results to public health authorities.". Reports Generated by BD Synapsys™ 3.84 Informatics Solution Simplify Mandatory Public Health Reporting. The BD MAX System is designed to help address today’s challenges, while preparing your laboratory for tomorrow’s possibilities. ... CerTest Biotec and BD Announce CE Mark for Combination COVID-19, Influenza, RSV Test on BD MAX™ Molecular Diagnostic System. The analyst gives the stock a $26 price target, which implies a 15% upside from current levels. The content is intended to be used for informational purposes only. The majority of NiSource’s customers, about 88%, are in the gas sector; the company’s electric operations serve customers in Indiana only. To prevent the attack of COVID-19, it is the best way to avoid getting exposure to coronavirus. "BD Synapsys™ Informatics unifies instrument-read COVID-19 test results from the BD Veritor™ and BD MAX™ systems," said Rajeev Sehgal, director of Informatics for BD Integrated Diagnostics Solutions. How Elon Musk and Jeff Bezos can help save our democracy. A better-ranked company in the broader medical sector is Stryker Corporation SYK. (To watch Porges’ track record, click here) Overall, there are 5 reviews on file, and all are to Buy, making the Strong Buy consensus unanimous. “…product/service inflation is only really a possibility AFTER re-openings, so the market feels a bit bullet proof in the very near term, and thus the continued rally, with Dems winning the GA races just adding fuel to the stimulus fire,” McCourt noted. (To watch Hovis' track record, click here) "NI shares appear favorably valued at 18.1-times our 2021 EPS estimate, below the average multiple of 21.6 for comparable electric and gas utilities," Hovis noted. In addition, the $31.54 average price target indicates ~9% upside potential. The content is intended to be used for informational purposes only. Boeing Co. got a bump in orders and deliveries of new planes in December, but it wasn’t enough to salvage a poor year for the big aircraft maker. Another risk McCourt sees, beyond those two, would be a sharp rise in inflation. Covering the stock for Leerink, analyst Geoff Porges remains bullish on Theravance, mainly due to the combination of its robust pipeline and its approved treatments for lung diseases. AT&T is a true large-cap industry giant, with a market cap of $208 billion and the largest network of mobile and landline phone services in the US. This is typical of utility companies in North America. Following the release, shares of this Zacks Rank #4 (Sell) company increased 2.8% to $237.31 at close. Overall, Wall Street sees a clear path forward for NiSource – a fact clear from the unanimous Strong Buy consensus rating, based on 3 recent Buy-side reviews. "NiSource could also become a buyout target, as larger utilitiesand private equity firms have purchased smaller utilities because oftheir stable earnings growth and above-average dividend yields." Here's a list featuring GRWG stock, Square, Daqo and four other stocks expecting up to 156% growth. Brazil's Bolsonaro to allow China's Huawei in 5G auctions: newspaper, Netflix has a high bar to clear as 2021 movie blitz takes shape, earnings in focus, Media mogul Haim Saban explains why the Fox-Disney merger ‘stumped’ him, Zurich Insurance to drop out of Nord Stream 2 project - sources, Betsy DeVos chose 'the powerful over the vulnerable’: Former Ed Secretary Arne Duncan, 3 tax breaks included Biden's economic 'rescue plan', Joe Biden's $1.9 trillion stimulus plan could wreck Wall Street's favorite money-making trade, Lối đi mới thoát "dốt" tiếng Anh cho người mất gốc, Fastest-Growing Stocks: Square Stock Among 7 Stocks Expecting Up To 156% Growth In 2021, Raymond James: 2 Big 7% Dividend Stocks to Buy Now, This crypto startup is offering 8.6% interest on savings accounts — 123 times the national average, IRS says this tax season will be ‘one of the nation’s most important.’ Make note of these key dates, Is the stock market open on Martin Luther King Jr. Day? For investors’ notice, CerTest Biotec is a Spanish developer and manufacturer of in-vitro diagnostic medical devices. The opportunity, in his opinion, stems from the obvious factors: the Democrats won both Georgia Senate seats in the recent runoff vote, giving the incoming Biden Administration majority support in both Houses of Congress – and increasing the odds of meaningful fiscal support getting signed into law in the near term. These Buy-rated tickers bring a dividend yield of 7%, a strong attraction for investors interested in using the current good times to set up a defensive firewall should the risks materialize. In line with these comments, Louthan rates T an Outperform (i.e. Used with the BD Veritor™ Plus System and/or the BD Max™ System, the BD Synapsys™ Informatics 3.84 solution allows customers to export all SARS-CoV-2 test results in a single daily report. Are any pot stocks good buys now amid profitability challenges? One analyst, however, thinks this lower stock price gives investors an attractive entry point today. Stay home* and follow CDC guidance on steps to take if you are sick. Argus analyst Gary Hovis rates NI a Buy along with a $32 price target. 7 Buy ratings, 6 Holds and 2 Sells add up to a Moderate Buy consensus. The BD SARS-CoV-2 Reagents for BD MAX™ System is a real-time RT-PCR test intended for the qualitative detection of nucleic acid from the SARS-CoV-2 in nasal, nasopharyngeal, and oropharyngeal swab samples from individuals suspected of COVID-19 by their healthcare provider. “Our research indicates that a value premium does exist and that the recent outperformance of growth stocks can be partially explained by downward-trending long-term inflation levels and the lack of material acceleration in earnings growth over the last decade,” the firm says. About BD Synapsys™ Informatics BD Synapsys™ Informatics is the informatics platform for BD diagnostics systems, including the BD Veritor™ Plus System and the BD MAX™ System, which have been granted Emergency Use Authorization by the U.S. Food and Drug Administration to perform SARS-CoV-2 diagnostic testing. COVID-19 Situation / COVID-19 claims 16 more, infects 813 in Bangladesh. There’s a thrill in finding a valuable stock at low, low price – and then watching it appreciate in the mid- to long-term. A report by MarketsandMarkets projects the global infectious disease diagnostics market to reach a worth of $19.35 billion in 2022, at a CAGR of 5.6%. This keeps the net earnings and revenues down, at least for the near-term, and leads to a discount share price – TBPH has slipped 32% over the past 52 weeks. We see EPD as arguably best positioned to withstand the volatile landscape… With EPD's footprint, demand gains, project growth, and contracted ramps should more than offset supply headwinds and lower y/y marketing results…" It’s not often that the analysts all agree on a stock, so when it does happen, take note. The company is a member in long standing of the S&P 500, and it has reputation as one of the stock market’s best dividend payers. It’s current pipeline includes drug candidates for the treatment of inflammatory lung and intestinal conditions, as well as neurogenicorthostatic hypotension. The solution also offers configured reporting capabilities, which allow customers in the U.S. to generate reports in accordance with the U.S. Coronavirus Aid, Relief, and Economic Security (CARES) Act. • Abbott ID Now COVID-19 • BD SARS-CoV-2 Reagents for BD MAX System • Biofire Antigen Testing: • BD Veritor System for Rapid Detection of SARS-CoV-2 • Quidel Sofia SARS Antigen FIA Antibody Testing: • Assure Ecotest COVID-19 IgG/IgM • Cellex qSARS-CoV-2 IgG/IgM Rapid Test . At 27–32 kb, coronavirus genomes are the largest among RNA viruses. Each of these drugs leverages novel delivery of unique compounds against proven mechanisms-of-action and could offer superior safety and/or treatment effect, from their wider therapeutic windows,” Porges noted. Fire / 500 houses burnt, 30 injured in Rohingya camp fire. Last year, it generated $24 billion in global revenues. BD Synapsys Informatics was among the first life science diagnostics informatics platforms to receive the Underwriters Laboratory Cybersecurity Assurance Program certification, an independent third-party evaluation that uses standardized, testable criteria for assessing software vulnerabilities and weaknesses. The BD Synapsys™ solution's new capabilities allow global customers to create general-purpose reports with COVID-19 data from their BD Veritor™ and/or BD MAX™ systems. Q3 earnings, at 48 cents per share, were just under the forecast, but were up 4% year-over-year and 2% sequentially. At a time when millions of people are strapped for money and counting on their income tax refund or a stimulus check, they’ll have to wait a little longer before they can file their taxes. IVD assays, research use only (RUO) assays and user-defined protocols (UDP) cannot be combined in the same rack. It contains all the components necessary for real-time PCR assay in a stabilized format as well as an internal control to monitor PCR inhibition.